Skip to main content
← Back to work

Works cited by this work

298 works

Work: Pyroptosis-inducing nanomedicines: A dual-mode therapeutic framework for apoptosis-resistant lung cancer

  1. The Cancer-Immunity Cycle in Multiple Myeloma

    Mika Casey, Kyohei Nakamura

    Review article20212 citations
    ABI
  2. Cancer immunoediting: from immunosurveillance to tumor escape

    Gavin P. Dunn, Allen T. Bruce, Hiroaki Ikeda +2

    Review article20022 citations
    ABI
  3. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

    Edward B. Garon, Naiyer A. Rizvi, Rina Hui +24

    Article20152 citations
    ABI
  4. The immune contexture in cancer prognosis and treatment

    Wolf H. Fridman, Laurence Zitvogel, Catherine Sautès‐Fridman +1

    Review article20172 citations
    ABI
  5. Mitochondria as multifaceted regulators of cell death

    Florian J. Bock, Stephen W. G. Tait

    Review article20192 citations
    ABI
  6. Pyroptosis: Gasdermin-Mediated Programmed Necrotic Cell Death

    Jianjin Shi, Wenqing Gao, Feng Shao

    Review article20162 citations
    ABI
  7. Cancer immunoediting and resistance to T cell-based immunotherapy

    Jake S. O’Donnell, Michele W.L. Teng, Mark J. Smyth

    Review article20182 citations
    ABI
  8. Polymeric Nanocarriers of Drug Delivery Systems in Cancer Therapy

    Nataša Avramović, Boris Mandić, Ana Savić-Radojević +1

    Review article20202 citations
    ABI